News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Test Predicts Novartis AG's Kinase Inhibitor Resistance in CML, Hokkaido University Study


7/29/2010 7:03:42 AM

MedPage Today -- A novel laboratory test may accurately distinguish which chronic myeloid leukemia (CML) patients will develop resistance to imatinib (Gleevec), researchers said.

Read at Newswise
Read at MedPageToday
Read at Reuters

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES